In a not-so-distant future, pharmacists at a local hospital may be able to manufacture and deliver nanomedicines tailored to the specific needs of patients with a rare disease diagnosis. According to a paper published today in Frontiers in Science, this could be possible thanks to a new device designed to boost access to gene therapy at a fraction of the cost.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
